Published in
JMIR Publications, JMIR Research Protocols, 3(5), p. e185
DOI: 10.2196/resprot.5872
Links
Tools
EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia
Journal article published in 2016 by
Angela E. Rankine-Mullings 
,
Courtney R. Little ,
Marvin E. Reid ,
Deanne P. Soares ,
Carolyn Taylor-Bryan ,
Jennifer M. Knight-Madden ,
Susan E. Stuber ,
Asha V. Badaloo ,
Karen Aldred ,
Margaret E. Wisdom-Phipps ,
Teresa Latham ,
Russell E. Ware
,
Courtney R. Little ,
Marvin E. Reid ,
Deanne P. Soares ,
Carolyn Taylor-Bryan ,
Jennifer M. Knight-Madden ,
Susan E. Stuber ,
Asha V. Badaloo ,
Karen Aldred ,
Margaret E. Wisdom-Phipps ,
Teresa Latham ,
Russell E. Ware
This paper is made freely available by the publisher.
Full text: Download
Data provided by 